Skip Navigation


Carcinogenesis Advance Access originally published online on October 27, 2006
Carcinogenesis 2007 28(3):749-759; doi:10.1093/carcin/bgl202
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/3/749    most recent
bgl202v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kim, D.S.
Right arrow Articles by McCabe, C.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, D.S.
Right arrow Articles by McCabe, C.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity

D.S. Kim1, J.A. Franklyn1, V.E. Smith1, A.L. Stratford1, H.N. Pemberton1, A. Warfield2, J.C. Watkinson1, T. Ishmail3, M.J.O. Wakelam4 and C.J. McCabe1,*

1 Division of Medical Sciences, Institute of Biomedical Research, University of Birmingham B15 2TH, UK
2 Department of Cellular Pathology (Histopathology), University of Birmingham UK
3 University Hospital Birmingham Trust Birmingham, UK
4 CRUK Institute for Cancer Studies, University of Birmingham UK

*To whom correspondence should be addressed. Tel:+44 121 415 8714; Fax: +44 121 415 8712; Email: mccabcjz{at}bham.ac.uk

Genetic instability (GI) is a hallmark feature of tumor development. Securin, also known as pituitary tumor transforming gene (PTTG), is a mitotic checkpoint protein which is highly expressed in numerous cancers, is associated with tumor invasiveness, and induces GI in thyroid cells. We used fluorescence inter-simple sequence repeat PCR to assess GI caused primarily by DNA breakage events in 19 colorectal tumors. GI values ranged significantly, with Dukes' stage C&D colorectal tumors exhibiting greater GI and higher securin expression than Dukes' stage A&B tumors. Consistent with these findings, we observed a dose-dependent increase in GI in HCT116 cells in response to securin overexpression, as well as in non-transformed human fibroblasts. As securin has been implicated in a novel DNA repair pathway in fission yeast, we investigated its potential role in chemotoxic DNA damage response pathways in mammalian cells, using host cell reactivation assays. Securin overexpression in HCT116 cells inhibited etoposide-induced double-stranded DNA damage repair activity, and repressed Ku heterodimer function. Additionally, we observed that securin and Ku70 showed a reciprocal cytosol–nuclear translocation in response to etoposide-induced dsDNA damage. Our data suggest that, by repressing Ku70 activity and inhibiting the non-homologous end-joining dsDNA repair pathway, securin may be a critical gene in the development of GI in colorectal cancer.

Abbreviations: DSB, double-strand break; dsDNA, double-stranded DNA; FISSR-PCR, fluorescence inter-simple sequence repeat polymerase chain reaction; GI, genetic instability; PK-DNA, protein kinase-dependent DNA repair; PTTG, pituitary tumor transforming gene; RLU, relative light units; VO, vector-only

Received May 18, 2006; revised October 11, 2006; accepted October 14, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
F. Salehi, K. Kovacs, B. W Scheithauer, R. V Lloyd, and M. Cusimano
Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update
Endocr. Relat. Cancer, September 1, 2008; 15(3): 721 - 743.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C. Zhou, Y. Tong, K. Wawrowsky, S. Bannykh, I. Donangelo, and S. Melmed
Oct-1 induces pituitary tumor transforming gene expression in endocrine tumors
Endocr. Relat. Cancer, September 1, 2008; 15(3): 817 - 831.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Chesnokova, S. Zonis, T. Rubinek, R. Yu, A. Ben-Shlomo, K. Kovacs, K. Wawrowsky, and S. Melmed
Senescence Mediates Pituitary Hypoplasia and Restrains Pituitary Tumor Growth
Cancer Res., November 1, 2007; 67(21): 10564 - 10572.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.